PepGen Inc (PEPG)
17.25
-0.23
(-1.32%)
USD |
NASDAQ |
Jun 14, 16:00
17.31
+0.06
(+0.35%)
After-Hours: 20:00
PepGen Free Cash Flow: -77.58M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -77.58M |
| December 31, 2023 | -71.60M |
| September 30, 2023 | -66.48M |
| June 30, 2023 | -71.17M |
| March 31, 2023 | -65.74M |
| Date | Value |
|---|---|
| December 31, 2022 | -63.02M |
| September 30, 2022 | -54.67M |
| June 30, 2022 | -40.95M |
| March 31, 2022 | -33.85M |
| December 31, 2021 | -23.10M |
Free Cash Flow Range, Past 5 Years
-77.58M
Minimum
Mar 2024
-23.10M
Maximum
Dec 2021
-56.82M
Average
-64.38M
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals Inc | 81.59M |
| Vertex Pharmaceuticals Inc | 3.479B |
| Sarepta Therapeutics Inc | -653.88M |
| PTC Therapeutics Inc | -199.47M |
| Regenxbio Inc | -198.64M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.53M |
| Cash from Investing (Quarterly) | -11.29M |
| Cash from Financing (Quarterly) | 86.97M |
| Free Cash Flow Per Share (Quarterly) | -0.7881 |
| Free Cash Flow Yield | -17.98% |